Cinclus Pharma (CINPHA) — Tangible Net Worth Ratio
Cinclus Pharma (CINPHA) has a Tangible Net Worth Ratio of 100.0% as of June 2026. This metric is calculated by deducting intangible assets (Skr0.00) from net assets (Skr202.70 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore how fast is Cinclus Pharma growing its equity to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Cinclus Pharma Tangible Net Worth Ratio (2022–2025)
This chart shows how Cinclus Pharma's Tangible Net Worth Ratio has changed across 3 annual periods from 2022 to 2025. As of June 2026, the ratio stands at 100.0%, reflecting net assets of Skr202.70 Million with intangible assets of Skr0.00 SEK. For live market cap and overall valuation, see Cinclus Pharma (CINPHA) total market value.
Annual Tangible Net Worth Ratio for Cinclus Pharma (2022–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Cinclus Pharma from 2022 to 2025, covering 3 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See Cinclus Pharma (CINPHA) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | Skr369.39 Million | Skr0.00 | Skr546.56 Million | ▲ +0.0 pp |
| 2024 | 100.0% | Skr555.33 Million | Skr0.00 | Skr601.01 Million | ▲ +0.0 pp |
| 2022 | 100.0% | Skr126.87 Million | Skr0.00 | Skr185.77 Million | — |